Loading

Short Communication Open Access
Volume 2 | Issue 3 | DOI: https://doi.org/10.46439/ophthalmology.2.017

Recent advances on visual cycle protein research and progress on clinical translation

  • 1Department of Molecular Science, University of Texas Rio Grande Valley School of Medicine, Edinburg, Texas, 78541, USA
  • 2Baylor College of Medicine, Houston, Texas, 77030, USA
  • 3Vision Health Specialties, Midland, Texas, 79707, USA
  • 4Texas Tech University Health Science Center, Midland, Texas, 79705, USA
+ Affiliations - Affiliations

Corresponding Author

Andrew Tsin, andrew.tsin@utrgv.edu

Received Date: July 16, 2020

Accepted Date: September 08, 2020

Abstract

Since the publication of our previous paper, Visual cycle proteins: Structure, function, and roles in human retinal disease (Tsin, et.al, JBC 293:13016, 2018) there has been significant progress on multiple topics discussed in this paper. In the present communication, we further explore research advances on two visual cycle proteins: DES1 and IRBP. In addition, we emphasize the progress of clinical translation of other visual cycle protein research, including the breakthrough of FDA-approved gene therapy for Leber’s congenital amaurosis, and additional gene therapies at different stages of clinical trials for various retinal diseases such as retinitis pigmentosa, diabetic retinopathy, and Stargardt’s disease. 

Keywords

Visual Cycle, DES1, IRBP, RPE 65, Gene Therapy, LCA, RP, DR, STGD

Author Information X